Binoy Sheth, DPM
Podiatrist · Allen, TXNPI 1710346101
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $116,000 of the $121,083 with a category attached, or 95.8%. Nvision Biomedical Technologies, Inc. accounts for 95.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $69,194 and has fallen 98.3% since, to $1,150 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $747.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nvision Biomedical Technologies, Inc.$116K
- Pylant Medical$1K
- Stryker$1K
- Amgen$643
- Treace Medical Concepts, Inc.$597
- Smith+Nephew$407
- plus $1K from 15 others
What the payments were for
- Royalty or licence$116,00096%
- Food & beverage$3,8833%
- Education$1,2001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nvision Biomedical Technologies, Inc. | 12 | $116,000 |
| Pylant Medical | 2 | $1,216 |
| Stryker | 24 | $1,174 |
| Amgen | 61 | $643 |
| Treace Medical Concepts, Inc. | 14 | $597 |
| Smith+Nephew | 17 | $407 |
| Medtronic | 13 | $331 |
| Nevro Corp. | 3 | $245 |
| Prugen, Inc. Pharmaceuticals | 1 | $95 |
| Bioventus LLC | 2 | $85 |
| Johnson & Johnson | 2 | $65 |
| Bone Support Inc. | 1 | $37 |
| Averitas Pharma Inc. | 1 | $36 |
| Orthofix Medical, Inc. | 2 | $29 |
| Abbott | 1 | $23 |
| Sandoz | 1 | $20 |
| CPM Medical Consultants, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Globus Medical | 1 | $16 |
| Organogenesis Inc. | 1 | $15 |
| Hartmann USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Expandable Subtalar Joint implant$68,750
- Radian$47,250
- ALLOGRAFT$233
- Senza$210
- Lapiplasty System$127
- ALLOGRAFT BIO-IMPLANTS$124
How this compares
$121,083 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 68 | $1,993 |
| Gabapentin | 13 | $593 |
| Methylprednisolone | 48 | $363 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $206 |
| Cephalexin | 21 | $189 |
| Mupirocin | 13 | $114 |
| Naproxen | 28 | $81 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Allen
- Lyle HaskellAllen$26K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.